<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.4" extension="2015-08-01"/>
  <id root="42eeae32-b6f4-4b2d-b832-5e25b5636ec1"/>
  <code code="11488-4" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Consult note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Medical Oncology Consultation — Audre Lorde</title>
  <effectiveTime value="20260330120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="0061c397-b18a-4f20-b207-6b25c3b72c88"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="8dc2cbae-b65b-436c-809f-ce25e202c30b" extension="HR-ML016-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-16-2937"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Audre</given><family>Lorde</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19810218"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260330120000-0500"/>
    <assignedAuthor><id root="26461aab-3886-4f1a-b0ba-8efdc014737f"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Beatriz</given><family>Lozano</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260330120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="26461aab-3886-4f1a-b0ba-8efdc014737f"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Beatriz</given><family>Lozano</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <inFulfillmentOf>
    <order><id root="8ebdd3f9-3ca7-4260-8f01-6bb9379e1c1c"/></order>
  </inFulfillmentOf>
  <documentationOf>
    <serviceEvent classCode="PCPR"><effectiveTime><low value="20260330"/><high value="20260330"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="26461aab-3886-4f1a-b0ba-8efdc014737f"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Beatriz</given><family>Lozano</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="07b44511-0e62-4396-a375-82eb39bcb79e"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Survivorship follow-up on the day of the medical oncology consultation</originalText></code>
      <effectiveTime><low value="20260330"/><high value="20260330"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="26461aab-3886-4f1a-b0ba-8efdc014737f"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Beatriz</given><family>Lozano</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.1" extension="2014-06-09"/>
    <code code="42349-1" codeSystem="2.16.840.1.113883.6.1" displayName="Reason for referral (narrative)"/>
    <title>Reason for Referral</title>
    <text><paragraph>Woman of 45, five and a half months after right total mastectomy for stage IA hormone receptor-positive, HER2-negative breast cancer, on tamoxifen since one month after surgery and now moving her survivorship care to primary care at this center. Please review the adjuvant endocrine plan and advise on hot flashes, surveillance, and genetic assessment, so that we can share her follow-up. [S]</paragraph><paragraph>Urgency: Routine, within four weeks. [S]</paragraph><paragraph>Questions for the consultant:</paragraph><list listType="ordered"><item>Is tamoxifen alone the right adjuvant endocrine therapy for her, or is ovarian function suppression or an aromatase inhibitor indicated, and for how long?</item><item>How should her hot flashes be managed safely alongside tamoxifen?</item><item>What surveillance does she need, and are any blood tests, tumor markers, or scans indicated?</item><item>Should she have germline genetic testing now, and would a result change her care?</item><item>What should primary care monitor on tamoxifen, and how should we share her follow-up?</item></list></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Lorde is seen at the request of Dr. Fairweather to share her survivorship care. She found a right breast lump at self-examination last September; a core biopsy showed invasive ductal carcinoma, and she had a right total mastectomy with flat closure and sentinel node biopsy at the end of September. She chose not to have reconstruction or wear a prosthesis, and this is respected. She has taken tamoxifen 20 mg daily for five months with three or four hot flashes a day, no abnormal vaginal bleeding, and no leg swelling or breathlessness. Her periods are regular. She has no bone pain, cough, headaches, abdominal pain, or new lumps. She walks and writes daily. She asked for the reasoning behind each recommendation. [S]</paragraph><paragraph>Historical basis. These claims are historical evidence, not findings from a modern examination.</paragraph><list><item>Audre Lorde was born Audrey Geraldine Lorde on February 18, 1934, in New York City; her parents were immigrants from Grenada. [D]</item><item>Lorde was a poet, essayist, and novelist. In her poetry and prose she wrote about matters important to her as a woman of color, as a lesbian, as a mother, and as a feminist; a reference biography describes her as an African American lesbian feminist and poet. [D]</item><item>In 1977 a doctor found a tumor in Lorde&apos;s breast that, after about three weeks of uncertainty, proved benign. In a talk given that year to the Modern Language Association she said: &quot;Your silence will not protect you.&quot; [D]</item><item>On Labor Day 1978, during a routine self-examination, Lorde found a lump in her right breast; a diagnosis of malignancy and a mastectomy followed. She described the experience in The Cancer Journals. [D]</item><item>After her mastectomy Lorde chose never to hide the fact of her missing breast. She refused to wear the &quot;wad of lambswool pressed into a pale pink breast-shaped pad&quot; pushed on her by nurses and medical counselors, and she was repeatedly scolded for posing a threat to cancer patient &quot;morale.&quot; [D]</item></list><paragraph>4 later historical claims are omitted because they describe events after the index age. See the teaching note.</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="c5d8ecd4-a499-4c63-a691-873507f27777"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260309"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="8841f738-0bc0-4852-8ad6-eb52a14fcb50"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Tamoxifen 20 mg oral tablet, one tablet by mouth once daily, planned for at least five years</td><td>One tablet once daily</td><td>Oral route</td><td>2025-10-27</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="f206075b-d15a-41d1-9f16-f33ab883de90"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20251027"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="313195" codeSystem="2.16.840.1.113883.6.88" displayName="tamoxifen 20 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="41ceb79f-5297-409d-b2b2-304fda9797db"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C50.411" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of upper-outer quadrant of right female breast"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="782889f8-db3b-4a3e-88ca-798a4f18ee31"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.810" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of selective estrogen receptor modulators (SERMs)"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Invasive ductal carcinoma of the upper outer quadrant of the right breast, stage IA (pT1c pN0(sn) M0), grade 2, estrogen and progesterone receptor positive, HER2 negative, recurrence score 14; treated by right total mastectomy with sentinel node biopsy and on adjuvant tamoxifen; synthetic modern counterpart of the documented 1978 breast cancer and mastectomy</td><td>active</td><td>confirmed</td>
    <td>C50.411</td><td>S — Synthetic tumor details and treatment; the diagnosis and the mastectomy are documented (D), but no tumor details from her lifetime are used.</td>
  </tr>
  <tr ID="problem-2">
    <td>Estrogen receptor positive status of the breast cancer (ER 90 percent, PR 60 percent)</td><td>active</td><td>confirmed</td>
    <td>Z17.0</td><td>S — Synthetic receptor result; no receptor status from her lifetime is known.</td>
  </tr>
  <tr ID="problem-3">
    <td>Absence of the right breast after mastectomy with flat closure; she chose not to have reconstruction and not to wear an external prosthesis</td><td>active</td><td>confirmed</td>
    <td>Z90.11</td><td>S — Synthetic coding of the documented mastectomy; the decision about a prosthesis echoes her documented choice and is respected as her own.</td>
  </tr>
  <tr ID="problem-4">
    <td>Long-term use of tamoxifen as adjuvant endocrine therapy</td><td>active</td><td>confirmed</td>
    <td>Z79.810</td><td>S — Synthetic treatment status.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="dcc13598-e763-4ab1-bb89-da7217285ff6"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260309"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="ceeb4c0b-7be3-484d-96ed-233df63ec163"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260309"/></effectiveTime>
          <value xsi:type="CD" code="C50.411" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of upper-outer quadrant of right female breast"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="b5eae708-5943-42c2-b2ea-7557417f9af0"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260309"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="055feba2-2598-480d-b058-9d558fb0b756"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260309"/></effectiveTime>
          <value xsi:type="CD" code="Z17.0" codeSystem="2.16.840.1.113883.6.90" displayName="Estrogen receptor positive status [ER+]"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="1dbbdbf2-82e2-4988-bf29-405d2a144f37"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260309"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="ffe8773e-a28d-4206-8c5c-0bbbce2e7853"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260309"/></effectiveTime>
          <value xsi:type="CD" code="Z90.11" codeSystem="2.16.840.1.113883.6.90" displayName="Acquired absence of right breast and nipple"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="c36246d9-12c2-4a6c-8617-3f1bbae8d33e"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260309"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="330070e5-65c1-4cef-aeb1-b442d91f1dbd"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260309"/></effectiveTime>
          <value xsi:type="CD" code="Z79.810" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of selective estrogen receptor modulators (SERMs)"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-03-30; see the referring visit&apos;s Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well</td></tr><tr><td>Breasts and chest wall</td><td>Right chest wall flat, scar healed, no nodules; left breast without masses</td></tr><tr><td>Lymph nodes</td><td>No axillary, supraclavicular, or cervical nodes</td></tr><tr><td>Extremities</td><td>No arm swelling; calves soft and non-tender</td></tr><tr><td>Abdomen</td><td>Soft; liver not enlarged</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section nullFlavor="NI">
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1"/>
    <title>Results</title>
    <text><paragraph>No results recorded at this visit.</paragraph></text>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.8"/>
    <code code="51848-0" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation note"/>
    <title>Assessment</title>
    <text><list listType="ordered"><item>Stage IA (pT1c pN0) hormone receptor-positive, HER2-negative right breast cancer after mastectomy (C50.411). Low risk of recurrence: small, node-negative, grade 2, with a recurrence score of 14, so chemotherapy is not indicated. Radiation is not needed after mastectomy with clear margins and negative nodes. For a premenopausal woman at this risk, tamoxifen alone is standard; ovarian function suppression adds benefit mainly at higher risk and is not recommended for her. An aromatase inhibitor would need ovarian suppression while she is premenopausal. [S]</item><item>Tamoxifen side effects (Z79.810). Mild hot flashes, common in the first year and often easing. Medicines that strongly inhibit CYP2D6 (paroxetine, fluoxetine, bupropion) may reduce the activation of tamoxifen and should be avoided. [S]</item><item>Surveillance. For stage I to III breast cancer without symptoms, follow-up is history, examination, and a yearly mammogram of the remaining breast. Routine blood counts, chemistry, tumor markers, and body imaging do not improve survival and are not recommended. Breast MRI is for women who meet high-risk criteria. [S]</item><item>Germline genetic assessment. Testing is recommended for all patients with breast cancer diagnosed at 65 or younger, and she was 44. A pathogenic variant would change her surveillance (adding breast MRI and possibly gynecologic risk reduction) and would matter to her relatives; a negative result would leave her plan unchanged. [S]</item></list><paragraph>Data reviewed: Outside diagnostic mammogram and ultrasound reports; core biopsy and mastectomy pathology with ER, PR, HER2, and Ki-67; sentinel node pathology (0 of 2); the 21-gene recurrence score of 14; her medication list; and the PHQ-9 and GAD-7 from Dr. Fairweather&apos;s visit three weeks ago. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.10" extension="2014-06-09"/>
    <code code="18776-5" codeSystem="2.16.840.1.113883.6.1" displayName="Plan of care note"/>
    <title>Plan of Treatment</title>
    <text><list><item>Continue tamoxifen 20 mg daily for at least five years, and consider ten years at the five-year review; no ovarian function suppression, aromatase inhibitor, or chemotherapy. [S]</item><item>Hot flashes: non-drug measures first (cooling, layered clothing, paced breathing, cognitive behavioral strategies); if they disturb sleep, venlafaxine 37.5 mg daily; avoid paroxetine, fluoxetine, and bupropion. [S]</item><item>Surveillance: cancer-related history and examination every three to six months for three years, then every six to twelve months to year five, then yearly; diagnostic mammogram of the left breast in September and yearly thereafter; no routine laboratory tests, tumor markers, or body imaging unless symptoms arise. [S]</item><item>Genetic counseling with multigene panel germline testing now. [S]</item><item>Primary care to ask at every visit about abnormal vaginal bleeding and symptoms of a clot, and to arrange a yearly gynecologic assessment; no routine pelvic ultrasound or endometrial biopsy without symptoms; no bone density test while she is premenopausal on tamoxifen alone. [S]</item><item>Lymphedema risk is low after sentinel node biopsy alone; check the arm at visits and refer to a lymphedema therapist if swelling appears. [S]</item><item>A written survivorship care plan by one year after diagnosis, with at least 150 minutes of activity a week, alcohol at or below one drink a day, and screening for distress at intervals. [S]</item><item>Her decision not to have reconstruction or wear a prosthesis is recorded; no further discussion unless she raises it. [S]</item><item>Discussed with Dr. Fairweather today; the patient agrees with the plan and was given the reasoning in writing, as she asked. [S]</item><item>Follow-up: Medical oncology review twice a year, alternating with primary care visits every three months in the first year. Primary care coordinates the mammogram, genetic counseling, gynecologic assessment, and distress screening. [S]</item></list></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
